| 1 |
Inhibitors can arrest the membrane activity of human islet amyloid polypeptide independently of amyloid formation. FEBS Lett. 2001 Oct 26;507(2):200-4.
|
| 2 |
Xpert MTB/RIF Ultra assay for tuberculosis disease and rifampicin resistance in children. Cochrane Database Syst Rev. 2022 Sep 6;9(9):CD013359.
|
| 3 |
ClinicalTrials.gov (NCT03801746) Drug-Drug Interaction Study of Vadadustat With Cyclosporine, Probenecid and Rifampin
|
| 4 |
ClinicalTrials.gov (NCT01341184) TMC207 +/- Rifabutin/Rifampin
|
| 5 |
ClinicalTrials.gov (NCT01002079) Drug-Drug Interaction Study With Rifampin
|
| 6 |
ClinicalTrials.gov (NCT00585195) A Study Of Oral PF-02341066, A C-Met/Hepatocyte Growth Factor Tyrosine Kinase Inhibitor, In Patients With Advanced Cancer
|
| 7 |
ClinicalTrials.gov (NCT03213145) Drug-drug Interaction Study Between EDP-305, Intraconazole and Rifampin in Healthy Volunteers
|
| 8 |
ClinicalTrials.gov (NCT02174250) The Effect of Rifampin on the Metabolism of Istradefylline in Healthy Volunteers.
|
| 9 |
ClinicalTrials.gov (NCT00207090) Effect of Rifampin on the Pharmacokinetics of Ixabepilone in Patients With Advanced Cancer
|
| 10 |
ClinicalTrials.gov (NCT05575297) A Drug-drug Interaction Study to Evaluate the Effect of Rifampicin and Febuxostat on the Pharmacokinetics of Methotrexate in Healthy Subjects
|
| 11 |
ClinicalTrials.gov (NCT04959266) A Study to Assess the Effects of Itraconazole, Rifampicin, and Omeprazole on Pharmacokinetics of Adavosertib
|
| 12 |
ClinicalTrials.gov (NCT02500667) A Drug-Drug Interaction Study of N91115 +/- Rifampin in Healthy Adult Subjects
|
| 13 |
ClinicalTrials.gov (NCT00042289) Pharmacokinetic Study of Antiretroviral Drugs and Related Drugs During and After Pregnancy
|
| 14 |
ClinicalTrials.gov (NCT02554318) Fermented Soybean Supplementation Among Active Pulmonary Tuberculosis Patients With Standard Therapy in Indonesia
|
| 15 |
ClinicalTrials.gov (NCT04532918) Pharmacokinetics of Verinurad and Allopurinol in Combination With Cyclosporine and Rifampicin in Healthy Volunteers
|
| 16 |
ClinicalTrials.gov (NCT00096850) Safety, Tolerability, and Blood Levels of Ritonavir-Boosted Atazanavir and Rifampin When Taken Together in HIV Uninfected Adults
|
| 17 |
ClinicalTrials.gov (NCT01768663) A Phase 1 Study to Examine the Drug-Drug Interaction of Ciprofloxacin, Itraconazole, and Rifampin on the Combination of Lumacaftor With Ivacaftor in Healthy Adult Subjects
|
| 18 |
ClinicalTrials.gov (NCT02372383) Improving Treatment of Nontuberculous Mycobacterial Infection in Cystic Fibrosis
|
| 19 |
ClinicalTrials.gov (NCT00776516) Pharmacokinetic Interaction Study to Assess the Effect of Repeat Doses of Rifampin on Mirabegron (YM178) in Healthy Volunteers
|
| 20 |
ClinicalTrials.gov (NCT00495326) Comparison of Nevirapine and Efavirenz for the Treatment of HIV-TB Co-infected Patients (ANRS 12146 CARINEMO)
|
| 21 |
ClinicalTrials.gov (NCT01336218) Effects of Administration of Fostamatinib on Blood Concentrations of Rifampicin in Healthy Subjects.
|
| 22 |
ClinicalTrials.gov (NCT01577862) Colistin and Rifampicin for MDR-Acinetobacter
|
| 23 |
ClinicalTrials.gov (NCT01218217) Early Bactericidal Activity (EBA) of SQ109 in Adult Subjects With Pulmonary TB
|
| 24 |
ClinicalTrials.gov (NCT01533870) Study in Healthy Volunteers to Investigate the Effects of Rifampin on the Pharmacokinetics of NKTR-118
|
| 25 |
ClinicalTrials.gov (NCT00877591) Interaction of Buprenorphine With HIV Medications and Tuberculosis Medications
|
| 26 |
ClinicalTrials.gov (NCT01251835) Effect Of Rifampin On Pharmacokinetics Of Sitaxsentan
|
| 27 |
ClinicalTrials.gov (NCT01765543) A Pharmacokinetics (PK) Study to Investigate the Effect of Rifampin on PK of Vemurafenib (Zelboraf)
|
| 28 |
ClinicalTrials.gov (NCT00439166) Effects of Doxycycline and Rifampicin on Biomarkers of Alzheimer's Disease in the Cerebrospinal Fluid
|
| 29 |
ClinicalTrials.gov (NCT01406002) To Evaluate if Multiple Doses of Rifampicin Change the Blood Concentration of YM150 (Darexaban)
|
| 30 |
ClinicalTrials.gov (NCT00057122) Tuberculosis Prevention for HIV Infected Adults
|
| 31 |
ClinicalTrials.gov (NCT00802802) Efavirenz (EFV) in HIV-Infected and HIV/Tuberculosis (TB) Coinfected Children
|
| 32 |
ClinicalTrials.gov (NCT01068756) Effect of Rifampin on the Pharmacokinetics of Dapagliflozin in Healthy Subjects
|
| 33 |
ClinicalTrials.gov (NCT01401933) Effect of Rifampin on the Pharmacokinetics of Linifanib in Subjects With Advanced or Metastatic Solid Tumors
|
| 34 |
ClinicalTrials.gov (NCT01756924) Safety and Efficacy of CEM-102 With Rifampin Compared to Standard Therapy in Patients With Prosthetic Joint Infections or Spacer Infection
|
| 35 |
ClinicalTrials.gov (NCT01324323) Influence of Rifampin on the Pharmacokinetics of Romidepsin in Patients With Advanced Cancer
|
| 36 |
ClinicalTrials.gov (NCT01571414) Evaluating the Safety and Drug Interaction of PA-824, an Investigational Tuberculosis Medication, Together With Efavirenz, Ritonavir-Boosted Lopinavir, or Rifampin
|
| 37 |
ClinicalTrials.gov (NCT02608034) A Study to Investigate the Effect of Itraconazole and Rifampin on Pharmacokinetics (PK) of Vemurafenib at Steady State
|
| 38 |
ClinicalTrials.gov (NCT00964106) Validation Study of Multiple Probe Compounds for Drug Interaction Evaluation
|
| 39 |
ClinicalTrials.gov (NCT06064539) Study of Drug-drug Interaction of the Effects of Gemfibrozil and Rifampicin on SAR442168 in Healthy Adult Subjects
|
| 40 |
ClinicalTrials.gov (NCT01969682) A Study to Assess the Effect of Rifampin on the Metabolism of ABT-199
|
| 41 |
ClinicalTrials.gov (NCT02019875) CYP3A4 Activity and Mineral Homeostasis
|
| 42 |
ClinicalTrials.gov (NCT01844583) Safety, Tolerability and Pharmacokinetic (PK) of Concomitant Esomeprazole and Rifampin, and QT Study on Single and Multiple-doses of Alisertib
|
| 43 |
ClinicalTrials.gov (NCT04118842) A Study in Healthy Subjects to Assess the Pharmacokinetics of Savolitinib When Administered Alone and in Combination With Rifampicin
|
| 44 |
ClinicalTrials.gov (NCT03723395) A Drug-Drug Interaction Study in Healthy Volunteers of the Effects of Tucatinib
|
| 45 |
ClinicalTrials.gov (NCT04312282) The Effect of Tesetaxel on the QTc Interval and the Effect of Food, Itraconazole, and Rifampin on Tesetaxel Pharmacokinetics in Patients With Advanced Solid Tumors
|
| 46 |
ClinicalTrials.gov (NCT04493931) Drug-drug Interaction Study of Gepotidacin
|
| 47 |
ClinicalTrials.gov (NCT02138799) A Study to Evaluate How a Drug That Alters Liver Enzymes (Rifampin) Affects the Metabolism of Enzalutamide in Men
|
| 48 |
ClinicalTrials.gov (NCT04557397) Fruquintinib CYP3A Inhibitor and Inducer Study
|
| 49 |
ClinicalTrials.gov (NCT02602509) Evaluating Celecoxib Activity in Mycobacterium Tuberculosis: A Whole Blood Bactericidal Activity Study in Healthy Volunteers
|
| 50 |
ClinicalTrials.gov (NCT02820935) Study to Evaluate the Effect of Cytochrome P450 (CYP) 3A Inhibition and Induction on the Pharmacokinetics of CC-220 in Healthy Subjects
|
| 51 |
ClinicalTrials.gov (NCT02253420) COPANLISIB (BAY80-6946) Drug-drug Interaction and Cardiovascular Safety Study in Advanced Solid Tumor and Non-Hodgkin's Lymphoma Patients
|
| 52 |
ClinicalTrials.gov (NCT06194864) Drug Interaction Study
|
| 53 |
ClinicalTrials.gov (NCT02097953) Influence of Rifampin Co-Administration on the Pharmacokinetic Profile of Daptomycin
|
| 54 |
ClinicalTrials.gov (NCT04537715) Study to Describe the Interaction Between Tazemetostat and Itraconazole and Between Tazemetostat and Rifampin in Participants With Advanced Cancer
|
| 55 |
ClinicalTrials.gov (NCT02046850) To Assess the Effect of Rifampicin on the Pharmacokinetics of Selumetinib in Healthy Male Volunteers
|
| 56 |
ClinicalTrials.gov (NCT03199690) A Clinical Study Investigating Rifampicin and Dolutegravir in Combination in Healthy Volunteers
|
| 57 |
ClinicalTrials.gov (NCT03077607) A Study to Evaluate the Effect of Itraconazole and Rifampin on the Pharmacokinetics of Talazoparib in Patients With Advanced Solid Tumors
|
| 58 |
ClinicalTrials.gov (NCT05766267) Short-course Regimens for the Treatment of Pulmonary Tuberculosis
|
| 59 |
ClinicalTrials.gov (NCT02256696) Assessing PA-824 for Tuberculosis (the APT Trial)
|
| 60 |
ClinicalTrials.gov (NCT05383742) Trial of a Six-Month Regimen of High-Dose Rifampicin, High-Dose Isoniazid, Linezolid, and Pyrazinamide Versus a Standard Nine-Month Regimen for the Treatment of Adults and Adolescents With Tuberculous Meningitis
|
| 61 |
ClinicalTrials.gov (NCT01785186) Evaluation of SQ109, High-dose Rifampicin, and Moxifloxacin in Adults With Smear-positive Pulmonary TB in a MAMS Design
|
| 62 |
ClinicalTrials.gov (NCT04311502) Clofazimine- and Rifapentine-Containing Treatment Shortening Regimens in Drug-Susceptible Tuberculosis: The CLO-FAST Study
|
| 63 |
ClinicalTrials.gov (NCT01589497) Essentiality of INH in TB Therapy
|
| 64 |
ClinicalTrials.gov (NCT05807399) PanACEA - STEP2C -01
|
| 65 |
ClinicalTrials.gov (NCT04630145) A Study of Bedaquiline Administered as Part of a Treatment Regimen With Clarithromycin and Ethambutol in Adult Patients With Treatment-refractory Mycobacterium Avium Complex-lung Disease (MAC-LD)
|
| 66 |
ClinicalTrials.gov (NCT02024555) Phase II Investigation of Antimycobacterial Therapy on Progressive, Pulmonary Sarcoidosis
|
| 67 |
ClinicalTrials.gov (NCT05896930) Study to Evaluate EBA, Safety and Tolerability of Carbapenems in Adults With Pulmonary Tuberculosis
|
| 68 |
ClinicalTrials.gov (NCT00130247) Tuberculosis Treatment Shortening Trial
|
| 69 |
ClinicalTrials.gov (NCT02581527) A Randomised Trial to Evaluate Toxicity and Efficacy of 1200mg and 1800mg Rifampicin for Pulmonary Tuberculosis
|
| 70 |
ClinicalTrials.gov (NCT04485156) Treatment Shortening of Drug-Sensitive Pulmonary Tuberculosis Using High Dose Rifampicin (Hi-DoRi-3)
|
| 71 |
ClinicalTrials.gov (NCT03236987) CLArithromycin Versus AZIthromycin in the Treatment of Mycobacterium Avium Complex (MAC) Lung Infections
|
| 72 |
ClinicalTrials.gov (NCT02701608) Oral Switch During Treatment of Left-sided Endocarditis Due to Multi-susceptible Staphylococcus
|
| 73 |
ClinicalTrials.gov (NCT02901288) Shortened Regimens for Drug-susceptible Pulmonary Tuberculosis
|
| 74 |
ClinicalTrials.gov (NCT04921943) Hypertonic Saline for MAC
|
|
|
|
|
|
|
